Sawyer, T.K.; Wibowo, A.S.; Carter, J.; Moussa, S.H. (2025). Crystal structure of the catalytic region of human MASP-2 with specific inhibitor Compound S2. Protein Data Bank: 9d3y. |
CMCF-ID |
PDB Deposition |
Health |
Sawyer, T.K.; Wibowo, A.S.; Carter, J.; Moussa, S.H. (2025). Crystal structure of the catalytic region of human MASP-2 with specific inhibitor Compound S1. Protein Data Bank: 9d17. |
CMCF-ID |
PDB Deposition |
Health |
Qiu, Y. (2025). Crystal structure of anti-abTCR NANOBODY VHH. Protein Data Bank: 9bdo. |
CMCF-ID |
PDB Deposition |
Health |
Lai, C.H.R.; Shah, M.; Nguyen, Q.H.; Moraes, T.F. (2025). Crystal structure of a Slam-dependent surface lipoprotein, PmSLP, in Pasteurella multocida. Protein Data Bank: 9b3e. |
CMCF-BM |
PDB Deposition |
Health |
Fontano, E.; Suto, R.K.; Olland, A.M. (2025). Structure of PAK1 in complex with compound 31. Protein Data Bank: 9d4y. |
CMCF-ID |
PDB Deposition |
Health |
Fan, S.; Wei, X.; Lv, R.; Wang, C.; Tang, M. et al. (2025). Crystal structure of serine hydroxymethyltransferase 1. Protein Data Bank: 8xnd. |
CMCF-ID |
PDB Deposition |
Health |
Kin S. YANG; Hang CHU; Solomon H. REISBERG; Wai Yan CHOY; Brian P. BESTVATER et al. (2025). Reversible lysine covalent modifiers of cdk2 and uses thereof. Patent Number: WO2025090658. |
CMCF-ID |
Patent |
Health |
Jean-Philippe Julien; Taylor Sicard; Anthony Semesi; Bebhinn Treanor; Tiantian Zhao et al. (2025). Nanoparticle platform for antibody and vaccine delivery. Patent Number: US20250114475A1. |
CMCF-ID |
Patent |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Powder pattern and hydrogen bonding in the crystal structure of phenelzine sulfate, C
8
H
14
N
2
(SO
4
). Powder Diffraction , 1-5. 10.1017/s0885715625000545. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of repotrectinib, C18H18FN5O2. Powder Diffraction , 1-6. 10.1017/s0885715625100882. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of palovarotene, C
27
H
30
N
2
O
2
. Powder Diffraction , 1-6. 10.1017/s0885715625100869. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of niraparib tosylate monohydrate Form I, (C
19
H
21
N
4
O)(C
7
H
7
O
3
S)(H
2
O). Powder Diffraction , 1-9. 10.1017/s0885715625000181. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of iprodione, C13H13Cl2N3O3. Powder Diffraction , 1-5. 10.1017/s0885715625100742. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of givinostat hydrochloride monohydrate Form I, C
24
H
28
N
3
O
4
Cl(H
2
O). Powder Diffraction , 1-6. 10.1017/s0885715625100559. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of ethynodiol diacetate, C
24
H
32
O
4
. Powder Diffraction , 1-6. 10.1017/s0885715625100729. |
BXDS-WLE |
Peer-Reviewed Article |
Health |